TCL Archive Cobimetinib-Zelboraf Therapy Increases OS In BRAF V600 Mutation-Positive Disease October 31, 2014
TCL Archive Cancer Groups Endorse Richard Pazdur for Head of FDA’s New Office of Oncology Drug Products. Five Candidates Are In the Running for the Job, Sources Said. February 18, 2005